DiaMedica Therapeutics Inc. financial data

Symbol
DMAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
301 Carlson Parkway, Suite 210, Minneapolis, MN
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Former names
DiaMedica Inc. (to 3/11/2014)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.62K % -3.54%
Return On Equity -43.7 % -5.87%
Return On Assets -40.8 % -4.91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.8M shares +12.7%
Common Stock, Shares, Outstanding 42.8M shares +12.7%
Entity Public Float 103M USD +96.2%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 42.8M shares +12.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 16.3M USD +39%
General and Administrative Expense 7.85M USD +2.04%
Operating Income (Loss) -24.1M USD -24.3%
Nonoperating Income (Expense) 1.93M USD +446%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -21.7M USD -20.7%
Income Tax Expense (Benefit) 43K USD +53.6%
Net Income (Loss) Attributable to Parent -21.7M USD -20.8%
Earnings Per Share, Basic -0.54 USD/shares +12.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.13M USD +85.2%
Marketable Securities, Current 46.1M USD +4.14%
Cash, Cash Equivalents, and Short-term Investments 50.2M USD -10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 290K USD -6.45%
Assets, Current 50.8M USD +6.02%
Property, Plant and Equipment, Net 151K USD +11.9%
Operating Lease, Right-of-Use Asset 298K USD -19.9%
Assets 52.5M USD -9.66%
Accounts Payable, Current 1.17M USD +35.7%
Employee-related Liabilities, Current 730K USD +28.1%
Accrued Liabilities, Current 3.02M USD +146%
Liabilities, Current 4.3M USD +98%
Operating Lease, Liability, Noncurrent 249K USD -26.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 81K USD
Retained Earnings (Accumulated Deficit) -132M USD -19.7%
Stockholders' Equity Attributable to Parent 48M USD -13.8%
Liabilities and Equity 52.5M USD -9.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.65M USD -30.7%
Net Cash Provided by (Used in) Investing Activities 4.21M USD +67.7%
Common Stock, Shares, Issued 42.8M shares +12.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.45M USD +5.23%
Deferred Tax Assets, Valuation Allowance 28M USD +23.3%
Operating Lease, Liability 337K USD -18.8%
Depreciation 8K USD +14.3%
Payments to Acquire Property, Plant, and Equipment 9K USD +28.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.5M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid 386K USD -21.9%
Property, Plant and Equipment, Gross 254K USD +9.48%
Operating Lease, Liability, Current 88K USD +12.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 116K USD +2.66%
Lessee, Operating Lease, Liability, to be Paid, Year One 113K USD +3.67%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 49K USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD +2.59%
Deferred Tax Assets, Operating Loss Carryforwards 26M USD +24%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10K USD -91.6%
Additional Paid in Capital 180M USD +8.33%
Deferred Tax Assets, Net of Valuation Allowance 28M USD +23.3%
Share-based Payment Arrangement, Expense 1.95M USD +19.2%